W M Wardell. Show Affiliations »
Abstract
Mesh: See more » Adrenergic beta-Antagonists/therapeutic useAnalgesics/therapeutic useAnti-Bacterial Agents/therapeutic useAnti-Infective Agents/therapeutic useAntihypertensive Agents/therapeutic useAntineoplastic Agents/therapeutic useBronchodilator Agents/therapeutic useCosts and Cost AnalysisDiuretics/therapeutic useDrug EvaluationDrug IndustryDrug-Related Side Effects and Adverse ReactionsHallucinogens/therapeutic useHypnotics and Sedatives/therapeutic useHypolipidemic Agents/therapeutic useLegislation, PharmacyPotassium/therapeutic useToxicologyTriterpenes/therapeutic useUnited KingdomUnited StatesUnited States Food and Drug AdministrationWorld Health Organization
Substances: See more » Adrenergic beta-AntagonistsAnalgesicsAnti-Bacterial AgentsAnti-Infective AgentsAntihypertensive AgentsAntineoplastic AgentsBronchodilator AgentsDiureticsHallucinogensHypnotics and SedativesHypolipidemic AgentsTriterpenesPotassium
Year: 1974 PMID: 4150345 DOI: 10.1002/cpt197415173
Source DB: PubMed Journal: Clin Pharmacol Ther ISSN: 0009-9236 Impact factor: 6.875